158 related articles for article (PubMed ID: 35880396)
1. Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma.
Hartmann S; Soltani AS; Bankov K; Bein J; Hansmann ML; Rosenwald A; Bernd HW; Feller A; Ott G; Möller P; Stein H; Klapper W; Borchmann P; Engert A; Eichenauer DA
Br J Haematol; 2022 Nov; 199(3):382-391. PubMed ID: 35880396
[TBL] [Abstract][Full Text] [Related]
2. Intranodular clusters of activated cells with T follicular helper phenotype in nodular lymphocyte predominant Hodgkin lymphoma: a pilot study of 32 cases from Finland.
Nathwani BN; Vornanen M; Winkelmann R; Kansal R; Doering C; Hartmann S; Hansmann ML
Hum Pathol; 2013 Sep; 44(9):1737-46. PubMed ID: 23684509
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
Visser L; Rutgers B; Diepstra A; van den Berg A; Sattarzadeh A
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999289
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the immune microenvironment for nodular lymphocyte-predominant Hodgkin lymphoma.
Binkley MS
Br J Haematol; 2022 Nov; 199(3):310-312. PubMed ID: 35993185
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte predominant cells of nodular lymphocyte predominant Hodgkin lymphoma interact with rosetting T cells in an immunological synapse.
Bein J; Thurner L; Hansmann ML; Hartmann S
Am J Hematol; 2020 Dec; 95(12):1495-1502. PubMed ID: 32815561
[TBL] [Abstract][Full Text] [Related]
6. Atypical variants of nodular lymphocyte-predominant Hodgkin lymphoma show low microvessel density and vessels of distention type.
Scheidt V; Hansmann ML; Schuhmacher B; Döring C; Hartmann S
Hum Pathol; 2017 Feb; 60():129-136. PubMed ID: 27816718
[TBL] [Abstract][Full Text] [Related]
7. Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.
Younes S; Subramanian A; Khan A; Zhao S; Binkley M; Natkunam Y
Blood Cancer J; 2024 May; 14(1):92. PubMed ID: 38821935
[TBL] [Abstract][Full Text] [Related]
8. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.
Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A
Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651
[TBL] [Abstract][Full Text] [Related]
9. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.
Boudová L; Torlakovic E; Delabie J; Reimer P; Pfistner B; Wiedenmann S; Diehl V; Müller-Hermelink HK; Rüdiger T
Blood; 2003 Nov; 102(10):3753-8. PubMed ID: 12881319
[TBL] [Abstract][Full Text] [Related]
10. Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.
Panayi C; Akarca AU; Ramsay AD; Shankar AG; Falini B; Piris MA; Linch D; Marafioti T
Front Oncol; 2023; 13():1267604. PubMed ID: 37854674
[TBL] [Abstract][Full Text] [Related]
11. Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG).
Hartmann S; Eichenauer DA; Plütschow A; Mottok A; Bob R; Koch K; Bernd HW; Cogliatti S; Hummel M; Feller AC; Ott G; Möller P; Rosenwald A; Stein H; Hansmann ML; Engert A; Klapper W
Br J Haematol; 2014 Oct; 167(2):238-42. PubMed ID: 24965443
[TBL] [Abstract][Full Text] [Related]
12. A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma.
Kiil K; Bein J; Schuhmacher B; Thurner L; Schneider M; Hansmann ML; Hartmann S
Virchows Arch; 2018 Dec; 473(6):759-764. PubMed ID: 30259184
[TBL] [Abstract][Full Text] [Related]
13. Geographic Variability of Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Xia D; Sayed S; Moloo Z; Gakinya SM; Mutuiri A; Wawire J; Okiro P; Courville EL; Hasserjian RP; Sohani AR
Am J Clin Pathol; 2022 Feb; 157(2):231-243. PubMed ID: 34542569
[TBL] [Abstract][Full Text] [Related]
14. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
[TBL] [Abstract][Full Text] [Related]
15. [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].
Hartmann S; Cogliatti S; Hansmann ML
Pathologe; 2013 May; 34(3):233-43. PubMed ID: 23494280
[TBL] [Abstract][Full Text] [Related]
16. CD57+ T-cells are a subpopulation of T-follicular helper cells in nodular lymphocyte predominant Hodgkin lymphoma.
Sattarzadeh A; Diepstra A; Rutgers B; van den Berg A; Visser L
Exp Hematol Oncol; 2015; 4():27. PubMed ID: 26380151
[TBL] [Abstract][Full Text] [Related]
17. IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma.
Prakash S; Fountaine T; Raffeld M; Jaffe ES; Pittaluga S
Am J Surg Pathol; 2006 May; 30(5):585-92. PubMed ID: 16699312
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
Hartmann S; Eichenauer DA; Plütschow A; Mottok A; Bob R; Koch K; Bernd HW; Cogliatti S; Hummel M; Feller AC; Ott G; Möller P; Rosenwald A; Stein H; Hansmann ML; Engert A; Klapper W
Blood; 2013 Dec; 122(26):4246-52; quiz 4292. PubMed ID: 24100447
[TBL] [Abstract][Full Text] [Related]
19. Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma.
Hartmann S; Eichenauer DA
Pathology; 2020 Jan; 52(1):142-153. PubMed ID: 31785822
[TBL] [Abstract][Full Text] [Related]
20. "Intrafollicular neoplasia" of nodular lymphocyte predominant Hodgkin lymphoma: description of a hypothetic early step of the disease.
Carbone A; Gloghini A
Hum Pathol; 2012 May; 43(5):619-28. PubMed ID: 22209342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]